Gene · 3269
Papers3,179
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,179
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Histamine H4 receptor and TRPV1 mediate itch induced by cadaverine, a metabolite of the microbiome. | Mol Pain | 2024 | 39079948 | PubTator, text mining | PubMed |
| Identification of HRH1 as an alternative receptor for SARS-CoV-2: insights from viral inhibition by repurposable antihistamines. | mBio | 2024 | 39037273 | PubTator, text mining | PubMed |
| TRPV1 and mast cell involvement in repeated variate stress-induced urinary bladder dysfunction in adult female mice. | Am J Physiol Renal Physiol | 2024 | 38991005 | PubTator, text mining | PubMed |
| Histamine H1 receptors in dentate gyrus-projecting cholinergic neurons of the medial septum suppress contextual fear retrieval in mice. | Nat Commun | 2024 | 38987240 | PubTator, text mining | PubMed |
| Pathophysiological role of histamine signaling and its implications in glioblastoma. | Biochim Biophys Acta Rev Cancer | 2024 | 38955315 | PubTator, text mining | PubMed |
| The histamine receptor H1 acts as an alternative receptor for SARS-CoV-2. | mBio | 2024 | 38953634 | PubTator, text mining | PubMed |
| Lower urinary dysfunction as a long-term effect of childhood vincristine treatment, with potential influences by sex and dose. | Sci Rep | 2024 | 38951167 | PubTator, text mining | PubMed |
| Terfenadine, a histamine H1 receptor antagonist, induces apoptosis by suppressing STAT3 signaling in human colorectal cancer HCT116 cells. | Front Pharmacol | 2024 | 38939837 | PubTator, text mining | PubMed |
| Establishment of a human nasal epithelium model of histamine-induced inflammation to assess the activity of fexofenadine as an inverse agonist and its link to clinical benefit. | Front Pharmacol | 2024 | 38933682 | PubTator, text mining | PubMed |
| Binding characteristics of the doxepin E/Z-isomers to the histamine H1 receptor revealed by receptor-bound ligand analysis and molecular dynamics study. | J Mol Recognit | 2024 | 38924170 | PubTator, text mining | PubMed |
| Reproductive and fetal toxicity studies of histamine H3 receptor antagonist DL76 used in mice to prevent maximal electroshock-induced seizure. | Front Pharmacol | 2024 | 38903994 | PubTator, text mining | PubMed |
| Construction and application of H1R ligand screening materials based on SMA stabilization and his-tag covalent immobilization of membrane proteins. | J Chromatogr A | 2024 | 38857565 | PubTator, text mining | PubMed |
| Deciphering the Systemic Impact of Herbal Medicines on Allergic Rhinitis: A Network Pharmacological Approach. | Life (Basel) | 2024 | 38792575 | PubTator, text mining | PubMed |
| Desloratadine ameliorates paclitaxel-induced peripheral neuropathy and hypersensitivity reactions in mice. | Acta Pharmacol Sin | 2024 | 38789495 | PubTator, text mining | PubMed |
| Clemastine and hyperthermia enhance sensitization of osteosarcoma cells for apoptosis. | Mol Cell Oncol | 2024 | 38778919 | PubTator, text mining | PubMed |
| Blocking H1R signal aggravates atherosclerosis by promoting inflammation and foam cell formation. | J Mol Med (Berl) | 2024 | 38733386 | PubTator, text mining | PubMed |
| Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells. | J Exp Clin Cancer Res | 2024 | 38715057 | PubTator, text mining | PubMed |
| Author Correction: Simultaneous activation of CXC chemokine receptor 4 and histamine receptor H1 enhances calcium signaling and cancer cell migration. | Sci Rep | 2024 | 38658635 | PubTator, text mining | PubMed |
| A phytosphingosine derivative mYG-II-6 inhibits histamine-mediated TRPV1 activation and MRGPRX2-dependent mast cell degranulation. | Int Immunopharmacol | 2024 | 38657498 | PubTator, text mining | PubMed |
| Dihydroergotamine Increases Histamine Brain Levels and Improves Memory in a Scopolamine-Induced Amnesia Model. | Int J Mol Sci | 2024 | 38612521 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3269/papers?page=7